Gallery: Human Trials of Inhalable Measles Vaccine Starting Soon


Needles are never fun. They hurt, they can cause infection and in some unfortunate cases, they can spread disease. That’s why researchers are developing an inhalable measles vaccine for the developing world, where clean needles aren’t always available. The vaccine, which is under development at CU Boulder, will begin human testing this summer.

Here’s how it works: researchers combine “supercritical” CO2 with a weakened measles virus, producing bubbles and drops that dry when warm nitrogen is applied. This dried vaccine can be inhaled through a small circular opening in a plastic sack, sending the protective powder into the patient’s lungs.

The first phase of human testing will begin in Pune, India, with 180 patients getting the powder. If all goes well, CU Boulder researchers might use the technique to produce vaccines for other diseases, including cervical cancer and tuberculosis.

+ University of Colorado

Via SmartPlanet


or your inhabitat account below


  1. Erwin Alber November 15, 2010 at 3:50 am

    I agree with Yellow Eyes. Vaccination was a failure beginning with Edward Jenner\’s vaccine against smallpox, but turned out to be such a profitable racket that it has been promoted as a triumph of medical science ever since. Dressed up as disease prevention, this organised criminal enterprise has developed into the multi-billion dollar industry it is today. Inhalable vaccines are just another version of this what basically amounts to a dangerous medical fraud.

  2. Yellow eyes May 7, 2010 at 9:41 am

    Another potential poisoning of people in another country to further a large pharmaceutical quest for profit from a childhood disease. This is not a breakthrough but, another assault by drug manufacturers to hook Americans with the notion that vaccines are the cure for everything. This subtle announcement should bring back memories of the recent H1N1 hysteria that the media played like a fiddle.

get the free Inhabitat newsletter

Submit this form
popular today
all time
most commented
more popular stories >
more popular stories >
more popular stories >
Federated Media Publishing - Home